Remove 2005 Remove Designs Remove Invention Remove Patent Infringement
article thumbnail

Claim Construction Order Sets Stage for Moderna v. Pfizer Vaccine Patent Showdown

Patently-O

by Dennis Crouch Moderna filed a patent infringement lawsuit against Pfizer and BioNTech in August 2022, alleging that the defendants COVID-19 vaccine infringes three patents related to Moderna’s mRNA vaccine technology. United States Patent Nos. 2005) (en banc). 10,898,574, 10,702,600, and 10,933,127.

Patent 97
article thumbnail

Supreme Court on Patent Law: November 2023

Patently-O

Specifically, the Board found MacNeil was entitled to a presumption that its evidence of commercial success, long-felt need, and industry praise related to its WeatherTech® product reflective of the inventiveness of the claims of the ’186 Patent. 408, 417 (2005). 101 as claiming only abstract ideas and no inventive concept.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biogen Seeks a Preliminary Injunction in Natalizumab BPCIA Case Against Sandoz

LexBlog IP

Biogen alleges infringement of twenty-eight patents under the BPCIA based on Sandoz’s submission of an aBLA for PB006, a proposed biosimilar of TYSABRI (natilizumab). ” Biogen seeks a judgment that Sandoz and Polpharma have infringed or will infringe the asserted patents, and preliminary and permanent injunctive relief.

article thumbnail

IP as Collateral

IIPRD

The subsidised valuation is done by government bodies like the Korea Invention Promotion Centre. The first step for declaring a patent as collateral involves the valuation of the patent to determine its objective value. If the patent is found valuable enough, the creditor proceeds with the loan.

IP 40